These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 24439735)

  • 1. Calcium-based phosphate binders and chronic kidney disease.
    Hiremath S; Akbari A
    Lancet; 2014 Jan; 383(9913):216. PubMed ID: 24439735
    [No Abstract]   [Full Text] [Related]  

  • 2. The demise of calcium-based phosphate binders.
    Ortiz A; Sanchez-Niño MD
    Lancet; 2013 Oct; 382(9900):1232-4. PubMed ID: 23870814
    [No Abstract]   [Full Text] [Related]  

  • 3. ACP Journal Club. Review: non-calcium-based phosphate binders reduce mortality compared with calcium-based binders in CKD.
    Parikh CR
    Ann Intern Med; 2013 Nov; 159(10):JC2. PubMed ID: 24247692
    [No Abstract]   [Full Text] [Related]  

  • 4. Evidence of comparative effectiveness without evidence of effectiveness: the case of phosphate binders in CKD.
    Uhlig K
    Am J Kidney Dis; 2014 Jan; 63(1):13-5. PubMed ID: 24200463
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis.
    Jamal SA; Vandermeer B; Raggi P; Mendelssohn DC; Chatterley T; Dorgan M; Lok CE; Fitchett D; Tsuyuki RT
    Lancet; 2013 Oct; 382(9900):1268-77. PubMed ID: 23870817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphate binders in CKD: bad news or good news?
    Drüeke TB; Massy ZA
    J Am Soc Nephrol; 2012 Aug; 23(8):1277-80. PubMed ID: 22797178
    [No Abstract]   [Full Text] [Related]  

  • 7. The efficacy and safety of sevelamer and lanthanum versus calcium-containing and iron-based binders in treating hyperphosphatemia in patients with chronic kidney disease: a systematic review and meta-analysis.
    Habbous S; Przech S; Acedillo R; Sarma S; Garg AX; Martin J
    Nephrol Dial Transplant; 2017 Jan; 32(1):111-125. PubMed ID: 27651467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should we be using calcium-containing phosphate binders in patients on dialysis?
    Spiegel DM; Block GA
    Nat Clin Pract Nephrol; 2008 Mar; 4(3):118-9. PubMed ID: 18212784
    [No Abstract]   [Full Text] [Related]  

  • 9. Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials.
    Navaneethan SD; Palmer SC; Craig JC; Elder GJ; Strippoli GF
    Am J Kidney Dis; 2009 Oct; 54(4):619-37. PubMed ID: 19692157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sevelamer Versus Calcium-Based Binders for Treatment of Hyperphosphatemia in CKD: A Meta-Analysis of Randomized Controlled Trials.
    Patel L; Bernard LM; Elder GJ
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):232-44. PubMed ID: 26668024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic kidney disease: Phosphate binder therapy--cracks in the tower of strength?
    Evenepoel P; Meijers B
    Nat Rev Nephrol; 2012 Nov; 8(11):615-6. PubMed ID: 23045230
    [No Abstract]   [Full Text] [Related]  

  • 12. Chronic kidney disease: calcium-based versus non-calcium-based phosphate binders: effect on mortality in patients with CKD.
    Allison SJ
    Nat Rev Nephrol; 2013 Sep; 9(9):491. PubMed ID: 23917795
    [No Abstract]   [Full Text] [Related]  

  • 13. A Review of Phosphate Binders in Chronic Kidney Disease: Incremental Progress or Just Higher Costs?
    St. Peter WL; Wazny LD; Weinhandl E; Cardone KE; Hudson JQ
    Drugs; 2017 Jul; 77(11):1155-1186. PubMed ID: 28584909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral phosphate binders in patients with kidney failure.
    Tonelli M; Pannu N; Manns B
    N Engl J Med; 2010 Apr; 362(14):1312-24. PubMed ID: 20375408
    [No Abstract]   [Full Text] [Related]  

  • 15. Update on phosphate binders: The old and the new.
    Cashin J; Battistella M
    CANNT J; 2016; 26(1):17-21; quiz 22-3. PubMed ID: 27215057
    [No Abstract]   [Full Text] [Related]  

  • 16. Optimal use of phosphate binders in chronic kidney disease.
    Sonikian M; Papachristou E; Goumenos DS
    Expert Opin Pharmacother; 2013 Dec; 14(18):2521-32. PubMed ID: 24215605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of phosphate binders in chronic kidney disease.
    Ketteler M; Biggar PH
    Curr Opin Nephrol Hypertens; 2013 Jul; 22(4):413-20. PubMed ID: 23736841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention and treatment of hyperphosphatemia in chronic kidney disease.
    Vervloet MG; van Ballegooijen AJ
    Kidney Int; 2018 May; 93(5):1060-1072. PubMed ID: 29580635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initiation of Sevelamer and Mortality among Hemodialysis Patients Treated with Calcium-Based Phosphate Binders.
    Komaba H; Wang M; Taniguchi M; Yamamoto S; Nomura T; Schaubel DE; Smith AR; Zee J; Karaboyas A; Bieber B; Fukagawa M; Tentori F
    Clin J Am Soc Nephrol; 2017 Sep; 12(9):1489-1497. PubMed ID: 28724618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Phosphate binders in chronic kidney disease: the positions of sevelamer].
    Fomin VV; Shilov EM; Svistunov AA; Milovanov IuS
    Ter Arkh; 2013; 85(6):96-9. PubMed ID: 23875200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.